Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide and Decitabine in r/r NHL after CAR-T
NCT04337606Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in non-Hodgkin lymphoma (NHL), sponsored by Chinese PLA General Hospital. Started Apr 2020; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT04337606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04337606.